Apex Labs Granted Approval for 160 Patient Macrodose Multi-Dose Psilocybin Clinical Trial by Health Canada
- Thursday, April 20, 2023, 7:11
- Business
- Add a comment
SUMMIT-90 statistically powered phase 2b study to evaluate APEX-90 macrodose synthetic psilocybin in-clinic with assisted psychotherapy VANCOUVER, BC, April 20, 2023 /PRNewswire/ – Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health…
About the Author
adminasapcorp has written 41555 stories on this site.